Volume | 499,836 |
|
|||||
News | - | ||||||
Day High | 234.40 | Low High |
|||||
Day Low | 229.85 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Charles River Laboratories International Inc | CRL | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
234.40 | 229.85 | 234.40 | 230.09 | 232.34 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
12,243 | 499,836 | $ 231.00 | $ 115,463,066 | - | 161.65 - 275.00 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:00:00 | 77,967 | $ 230.09 | USD |
Charles River Laboratories International Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
11.81B | 51.35M | - | 4.13B | 474.62M | 9.24 | 24.87 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Charles River Laboratories News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRL Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 249.23 | 250.72 | 229.85 | 240.88 | 396,626 | -19.14 | -7.68% |
1 Month | 266.33 | 274.765 | 229.85 | 257.32 | 424,674 | -36.24 | -13.61% |
3 Months | 216.05 | 275.00 | 211.23 | 246.73 | 529,171 | 14.04 | 6.50% |
6 Months | 190.79 | 275.00 | 161.65 | 220.62 | 543,796 | 39.30 | 20.60% |
1 Year | 204.60 | 275.00 | 161.65 | 211.38 | 518,439 | 25.49 | 12.46% |
3 Years | 321.95 | 460.21 | 161.65 | 256.59 | 518,059 | -91.86 | -28.53% |
5 Years | 138.86 | 460.21 | 95.58 | 232.48 | 451,629 | 91.23 | 65.70% |
Charles River Laboratories Description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services. |